Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Clinical trial NCT06341647 · WITHDRAWN

Trial details

NCT number: NCT06341647
Sponsor: GC Cell Corporation
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2024-10-31
Primary completion: 2027-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.